Clinical trial Recruiting at 1 site Interventional

REFLECT Scoliosis Correction System Post-Approval Registry

Official title: A Prospective, Single-Arm, Multi-Center, Registry Post-Approval Study of Growth Modulation in the Treatment of Idiopathic Scoliosis With the REFLECT™ Scoliosis Correction System

Run by Globus Medical Inc · NCT06298812 · Data updated 2026-11-12

This project will try the REFLECT Scoliosis Correction System in 100 skeletally immature patients with progressive idiopathic scoliosis (Cobb 30–65°) to see if it improves spine curvature and function over five years.

Quick facts

Study typeInterventional
SexAll
Enrollment100 (estimated)
SponsorGlobus Medical Inc
Industry-sponsored
Locations2 sites (Rochester, Minnesota and 1 other locations)
StatusRecruiting
StartedApril 8, 2024
Main results expectedMarch 31, 2027
Study endsMarch 31, 2032
Registry record updatedFebruary 13, 2026
Trial IDNCT06298812 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are skeletally immature patients with progressive idiopathic scoliosis, a major Cobb angle of 30–65°, side‑bending flexibility ≤30°, who have failed or are intolerant of bracing and have bone anatomy suitable for screw fixation.

Probably not a fit

Patients with prior spinal surgery at the levels to be treated, poor bone quality, active infection, non‑idiopathic scoliosis, skeletal maturity, or inability/unwillingness to follow postoperative care are unlikely to benefit from this device.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The REFLECT Post‑Approval Registry is a prospective, single‑arm, multi‑center effort enrolling 100 skeletally immature patients with progressive idiopathic scoliosis who have failed or are intolerant of bracing. All participants will receive the REFLECT Scoliosis Correction System, a non‑rigid growth‑modulation implant designed to hold spinal segments in a more anatomic position while permitting continued growth and mobility. Patients will be followed at preoperative, immediate postoperative, 6 weeks, 6 months, 12 months, 24 months and 60 months with radiographic measures and clinical outcomes collected at each timepoint. Primary and secondary outcomes from the cohort will be summarized to satisfy post‑approval monitoring requirements.

Why it matters

Potential benefit: If successful, the device could provide a surgical option that gradually corrects scoliosis while preserving spinal growth and motion, potentially reducing the need for spinal fusion.

How similar studies have gone: Similar growth‑modulation approaches such as vertebral body tethering have shown promising early results, but long‑term comparative data are still limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of progressive idiopathic scoliosis
* Preoperative major Cobb angle 30°-65°
* Preoperative flexibility to ≤30° on side bending radiograph (left or right)
* Skeletally immature at the time of surgery with Risser sign \<5 or Sanders score \<8
* Osseous structure dimensionally adequate to accommodate screw fixation, as determined by radiographic imaging
* Failed or intolerant to bracing
* Signed informed consent and/or assent forms specific to this study

Exclusion Criteria:

* Prior spinal surgery at the level(s) to be treated
* Documented poor bone quality, defined as a T-score of -1.5 or less
* Presence of any systemic infection, local infection, or skin compromise at the surgical site
* Any medical or surgical condition which would preclude the potential benefit of spinal surgery, such as coagulation disorders, allergies to the implant materials, and patient's unwillingness or inability to cooperate with post-operative care instructions
* Unwillingness, inability, or living situation (e.g. custody arrangements, homelessness, detention) that would preclude ability to return to the study site for follow-up visits as described in protocol and Informed Consent
* Active participation in a drug or device study that is more than minimal risk such that participation would confound the measurements of the present study

Where it's running

  • Mayo Clinic
    Rochester, Minnesota, United States
    Recruiting
  • New York University
    New York, New York, United States
    Enrolling by invitation

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.